ADTX
Aditxt, Inc.
$0.01
+0.00 (+0.00%)
At close · Jul 2
Going-concern doubt
— flagged May 20, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Because of these factors, the Company believes that this creates substantial doubt with the Company’s ability to continue as a going concern.”View the 10-Q filed May 20, 2026
Market Cap
$4,243
Shares
815,921
Price & Indicators
Indicators
Price
Panels
Event markers
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$0.01
Open$0.01
Day$0.01–0.01
52W$0.00–1,220.40
Avg vol 30d799.6M
Short int281K · 34.5% float · 1.0d
Short vol29%
Last earningsNov 13, 2020
DataJun 2020–Jul 2026
Filing10-Q · May 20
Equibles Rating
blended score · not investment advice
Overall
Neutral
Technical · trend & momentum
Sell
◦
50 / 200-day cross
no cross
−
Price vs 200-day avg
−100% below
−
Price vs 50-day avg
−98% below
◦
RSI (14)
38 · neutral
+
MACD trend
positive
−
52-week position
0% · near low
Sentiment · smart money
Bearish
◦
Trend (MA cross)
50d $0 › 200d $98 — 200d above 50d
−
Institutional flow
-93% holders QoQ
+
Insider flow
Net +$28.4K over 90 days · 71% sells
−
Short interest
34.50% of float · ▲ +201.6% MoM · 1.0 days cover
◦
Volume signal
Volume near normal
◦
Institution breadth
1 holders — 13F breadth
Fundamentals
Strong
−
Revenue growth
−98% Y/Y
+
Gross margin
8%, expanding
+
EPS growth
+100% Y/Y
−
Free cash flow
$-25.7M
+
Valuation
P/E 0 · below peers
+
Balance sheet
net cash $833.0K
Blended from price, positioning & fundamentals · daily-close · not investment advice.
Up next
FQ3-26 quarter ends
~Sep 30, 2026
Est
filed May 20, 2026
Technicals
trend & momentum for long-term holders Sell
50 / 200-day cross
no cross
Neutral
Price vs 200-day avg
−100% below
Bearish
Price vs 50-day avg
−98% below
Bearish
RSI (14)
38 · neutral
Neutral
MACD trend
positive
Bullish
52-week position
0% · near low
Bearish
Market signals — smart money & positioning
Bearish · 2 of 6
Trend (MA cross)
No cross
50d $0 › 200d $98 — 200d above 50d
Institutional flow
Distributing
-93% holders QoQ
Insider flow
Accumulating
Net +$28.4K over 90 days · 71% sells
Short interest
Rising
34.50% of float · ▲ +201.6% MoM · 1.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
1 holders — 13F breadth
Price context
position in its 52-week range
52-wk low $0
Now $0 · 0%
52-wk high $1,220
vs 200-day avg -100%
vs 50-day avg -98%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Biotechnology — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
ADTX
this stock
Aditxt, Inc.
|
$4,243 | -99.9% | -97.6% | 0.0 | 34.5% |
|
AKTX
Akari Therapeutics Plc
|
$953.21B | -9.9% | — | — | 0.0% |
|
ONC
BeOne Medicines Ltd.
|
$470.30B | -2.0% | +22179.2% | 957.1 | 0.1% |
|
VRTX
Vertex Pharmaceuticals Inc / Ma
|
$134.02B | +16.5% | +46.2% | 31.3 | 1.8% |
|
REGN
Regeneron Pharmaceuticals, Inc.
|
$69.80B | -15.1% | +20.8% | 16.3 | 3.2% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Smart Money
Financials
Filings
Earnings & Events
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| ADTX | +150.0% | -94.7% | -99.9% | -16.7% | -99.9% |
| SPY | +1.4% | -1.3% | +8.0% | -0.3% | +9.2% |
| vs SPY | +148.6% | -93.5% | -108.0% | -16.4% | -109.2% |